Like I stated this morning in Post #: 78532431 people who obviously work at the excuse factory like to hide behind the word "expect" (or in other cases I have seen on HC, the word 'potential') as an out for accountability of registered officeholders - trust me Mesoblast aren't the only company in this regard ?
What I expect is:
If a CEO is going to call out a CC 6 weeks in advance that what he claims in said CC will be a lot closer to the mark than what actually takes place in the self appointed quoted time frames - in this case 4 weeks. This is what he said:
You're going to see a ramp-up of enrollment in short order. We've invested substantially in sites. The number of centers that are coming on board that are onboard now is approximately 15. We expect over the coming four weeks to get up to about 40.
Why couldn't he simply say "We expect to see a ramp-up of enrollment in the coming weeks" .... and leave it there ? If we had of opened another 15 or so sites in the last 5 weeks, I would give the guy a round of applause as the number would be sitting at around 30 and a lot closer to 40 than the current figure of just under half that .... but a measly 3 of the anticipated 25 additional sites touted / estimated by him in the CC ??? He's the CEO and his expected number versus actual is an epic fail no matter how you paint it with semantics and his role he should have a better understanding of where things are at - just sayin'
Do you expect people to apply your logic / terminology to expected revenues if SI quotes same publicly and they are an also an epic fail once 'actuals' are revealed ..... "Oh he used the term 'expects' so the $32 million shortfall in actuals in the HY is just fine ?
I like the company and I am a LT shareholder who has participated in the last 2 CR's ($1.40 and 30 cents) and have my strategy locked in for the next 2 years, but IMHO people give SI's comments far too much leeway - that's my opinion on the matter and yes it differs from yours and that's life .... enjoy your day![]()
- Forums
- ASX - By Stock
- MSB
- Ann: Meeting Requested with FDA on Revascor Accelerated Approval
MSB
mesoblast limited
Add to My Watchlist
0.64%
!
$1.58

Ann: Meeting Requested with FDA on Revascor Accelerated Approval, page-63
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.58 |
Change
0.010(0.64%) |
Mkt cap ! $2.012B |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.57 | $6.922M | 4.377M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 81831 | $1.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.58 | 4000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 81831 | 1.570 |
4 | 63566 | 1.565 |
11 | 58221 | 1.560 |
4 | 42084 | 1.555 |
15 | 145066 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.580 | 4000 | 1 |
1.585 | 33603 | 1 |
1.590 | 54602 | 7 |
1.595 | 40154 | 3 |
1.600 | 58554 | 5 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |